Nerivio received clearance in January 2021 for use in acute migraine.
Isabella Ciccone, MPH
Advertisement
Articles by Isabella Ciccone, MPH
Advertisement
Latest Updated Articles
FDA: Nerivio Cleared for Migraine PreventionMarch 2nd 2023
Advertisement
Advertisement
Trending on Drug Topics
1
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
2
How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status
3
FDA Approves Onswik Weekly Insulin for Adults With T2D
4
Menopause Status, Symptoms Remain Inconsistently Documented
5